跳至主要内容
临床试验/NCT07594223
NCT07594223尚未招募不适用

Efficacy of Activator Trigger Point and Shock Wave Therapy on Pain and Function in Active Upper Trapezius Trigger Points: A Randomized Controlled Study

Cairo University1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年7月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
试验地点
1

研究概览

简要总结

This study will be conducted as a randomized controlled trial to evaluate the efficacy of trigger point activator and extracorporeal shock wave therapy in patients with active myofascial trigger points in the upper fibers of the trapezius muscle. Participants who meet the inclusion criteria will be recruited and informed consent will be obtained prior to participation. The subjects will then be randomly allocated into two equal groups. Group A: will receive treatment using the trigger point activator applied to the active trigger points of the upper trapezius muscle. Group B: will receive extracorporeal shock wave therapy applied to the same region.

The treatment will be applied according to standardized therapeutic parameters for a predetermined number of sessions over the study period. Outcome measures will be assessed before the beginning of the treatment program and after completion of the intervention period. Pain intensity and pressure pain threshold will be assessed using an algometer. Functional disability related to the neck will be evaluated using the Neck Disability Index (NDI). All collected data will be recorded and statistically analyzed to determine the effectiveness of both treatment modalities in reducing pain and improving functional outcomes.

详细描述

This study will be conducted as a randomized controlled trial to evaluate the efficacy of trigger point activator and extracorporeal shock wave therapy in patients with active myofascial trigger points in the upper fibers of the trapezius muscle. Participants who meet the inclusion criteria will be recruited and informed consent will be obtained prior to participation. The subjects will then be randomly allocated into two equal groups. Group A: will receive treatment using the trigger point activator applied to the active trigger points of the upper trapezius muscle. Group B: will receive extracorporeal shock wave therapy applied to the same region.

The treatment will be applied according to standardized therapeutic parameters for a predetermined number of sessions over the study period. Outcome measures will be assessed before the beginning of the treatment program and after completion of the intervention period. Pain intensity and pressure pain threshold will be assessed using an algometer. Functional disability related to the neck will be evaluated using the Neck Disability Index (NDI). All collected data will be recorded and statistically analyzed to determine the effectiveness of both treatment modalities in reducing pain and improving functional outcomes. 15. Participants of the study:

  1. The number of participants: 200 (50 per group to ensure 40 completers per arm after attrition).
  2. Important characteristics
  • Adult (27:40 years):
  • Gender: both gender
  • Diagnosis: Active upper trapezius trigger points Inclusion criteria
  1. Male or female participants aged between 25 and 40 years.
  2. Body Mass Index (BMI) between 20 and 30 kg/m².
  3. Presence of active myofascial trigger points in the upper fibers of the trapezius muscle confirmed by clinical examination.
  4. Complaints of neck pain associated with upper trapezius trigger points.
  5. Ability and willingness to participate in the treatment sessions and follow the study protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
27 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 1. Male or female participants aged between 25 and 40 years.
  • Body Mass Index (BMI) between 20 and 30 kg/m². 3.Presence of active myofascial trigger points in the upper fibers of the trapezius muscle confirmed by clinical examination.
  • Complaints of neck pain associated with upper trapezius trigger points.
  • Ability and willingness to participate in the treatment sessions and follow the study protocol.

排除标准

  • 1. History of neck trauma, cervical spine fracture, or cervical spine surgery.
  • Presence of neurological disorders affecting the cervical region.
  • Presence of cervical disc prolapse or severe cervical spine pathology.
  • Diagnosis of fibromyalgia or systemic musculoskeletal disorders.
  • Presence of skin diseases, wounds, or infections at the treatment area.
  • Patients with malignancy or severe systemic diseases.

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mina Magdy Wahba

Department of Physical Therapy for Orthopedics, Faculty of Physical Therapy

Suez University

研究点 (1)

Loading locations...

相似试验